Autism Disorder and Treatment Market Top Leading Players with Strategies and Forecast 2027
Market Insights
Autism, otherwise known as autism spectrum disorder
is a developmental disorder which affects cognitive function, social skills,
and overall emotional & physical health of the afflicted individual. The
disorder may occur at varying levels of severity and early identification is
often a crucial step in treatment.
Market Research Future (MRFR) has recently
published a report on the global autism disorder and treatment market which
reveals a steady CAGR of 4.37% during the forecast period 2017 to 2023. Gradual
prevalence of autism, growing awareness and the development of various forms of
treatment for the disorder are some essential factors driving growth.
Advancing technology coupled with research and
development of treatment options have provided scope for the market to grow.
With so many unanswered questions about autism, R&D is predicted to be the
key motivator of growth for the global market. Other factors include rising
awareness programs sponsored by government bodies and the increased
availability of generic pharmaceuticals for affordable treatment.
Meanwhile, stringent regulations associated with
product approvals are expected to hamper market growth. However, the unrealized
potential of this market is likely to create opportunities. Additionally,
stricter parameters for product approvals will likely lead the market to focus
on genuinely effective treatment options.
Key Players
Analysis
of the competitive landscape of the global autism disorder and treatment market
includes prominent market players such as Consern Pharma Private Limited,
Novartis AG, Johnson & Johnson Services Inc., Pfizer Inc., Eli Lilly and
Company, Allergan, Merck & CO Inc., Teva Pharmaceutical Industries Ltd.,
Bristol-Myers Squibb, Otsuka Holdings Co. Ltd., Intra-Cellular Therapies Inc.,
Saniona AB, Coronis Partners Ltd., Curemark LLC, and Heptares Therapeutics
Limited.
Get Sample Report: https://www.marketresearchfuture.com/sample_request/1605
Market Segmentation
The global autism disorder & treatment market
has been evaluated by segments to provide conclusive insights regarding market
growth. The market has been segmented on the basis of type, treatment type,
drugs, and region.
By type, the
market has been segmented into Asperger Syndrome, and Pervasive Developmental
Disorder (PDD). PDD possesses the most significant market segment by type and
is expected to witness a CAGR of 4.73% during the forecast period of 2017 to
2023.
By treatment type, the market has been segmented into Applied
Behavioral Analysis (ABA), hyperbaric oxygen therapy, chelation therapy, and
oxytocin therapy. Among these, the ABA segment is expected to achieve a CAGR of
4.82% during the forecast period.
By drug, the
market has been segmented into SSRIs, anti-convulsant, stimulants,
anti-psychotic. Anti-psychotics have been sub-segmented into Abilify
(aripiprazole) and Risperidone. The anti-psychotic segment, which presently
accounts for the largest segment by drug, is predicted to grow at a modest CAGR
of 3.95% during the forecast period.
By region, the
market has been segmented into the Americas, Europe, the Asia Pacific and the
Middle East & Africa.
Regional Analysis
The Americas have the largest global market share,
with North America leading market growth for the region. This is primarily due
to the widespread awareness of the disorder which has increased early
screening, thus facilitating market growth. Moreover, FDA approvals of atypical
antipsychotics have further encouraged growth.
Europe closely follows the Americas’ lead and is
expected to follow a similar growth pattern over the forecast period.
The Asia Pacific is the fastest growing global
market share due to the increasing demand for treatment options and increased
awareness of the disorder. Modern diagnostic tools and a better understanding
of autism are expected to motivate significant growth for the region during the
forecast period.
Meanwhile, the Middle East & Africa is expected
to exhibit steady yet limited growth. This is due to the lack of awareness and
social stigma associated with such disorders particularly in developing
countries of the African region. Middle Eastern countries such as Qatar and the
U.A.E, however, have schools and organizations dedicated to spreading
awareness, this motivating steady growth for the region.
Latest Industry News
"We Rock the Spectrum" in New Jersey is a
unique gym which has been created with the aim to provide a sensory safe space
for children with autism and other developmental disorders. The equipment in
the gym has been specially designed to cater to these children and provide them
with a safe space.
The Food & Drug Administration (FDA) has given
a fast track designation to a drug which is designed to improve the core
symptoms associated with autism. Still under development, the medication,
L1-79, was fast-tracked after a small clinical study proved it's potential. The
company behind this potentially revolutionary drug is Yamo Pharmaceuticals.
Additional trials are planned.
Browse Full Report: https://www.marketresearchfuture.com/reports/autism-disorder-and-treatment-market-1605
Related Report: U.S.
Direct Anterior Approach Market Research Report –Global Forecast to 2027
Magnetic
Resonance Imaging (MRI) Market Research Report – Forecast to 2027
Endometrial
Cancer Market Research Report – Forecast to 2027
Digital
Wound Measurement Devices Market Research Report – Forecast to 2027
Flow
Cytometry Market Research Report – Forecast to 2027
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to
unravel the complexity of various industries through our Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum
quality market research and intelligence services to our clients. Our market
research studies by products, services, technologies, applications, end users,
and market players for global, regional, and country level market segments,
enable our clients to see more, know more, and do more, which help to answer
all their most important questions.
In order to stay updated with technology and work process of
the industry, MRFR often plans & conducts meet with the industry experts
and industrial visits for its research analyst members.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
Comments
Post a Comment